Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Utah Medical Products (UTMD) FCF Payout Ratio (2016 - 2025)

Historic FCF Payout Ratio for Utah Medical Products (UTMD) over the last 16 years, with Q3 2025 value amounting to 0.26.

  • Utah Medical Products' FCF Payout Ratio fell 813.22% to 0.26 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.29, marking a year-over-year increase of 1478.93%. This contributed to the annual value of 0.29 for FY2024, which is 4746.12% up from last year.
  • Utah Medical Products' FCF Payout Ratio amounted to 0.26 in Q3 2025, which was down 813.22% from 0.35 recorded in Q2 2025.
  • Over the past 5 years, Utah Medical Products' FCF Payout Ratio peaked at 1.76 during Q4 2021, and registered a low of 0.16 during Q1 2023.
  • In the last 5 years, Utah Medical Products' FCF Payout Ratio had a median value of 0.23 in 2021 and averaged 0.33.
  • Its FCF Payout Ratio has fluctuated over the past 5 years, first skyrocketed by 89067.6% in 2021, then tumbled by 8943.76% in 2022.
  • Over the past 5 years, Utah Medical Products' FCF Payout Ratio (Quarter) stood at 1.76 in 2021, then crashed by 89.44% to 0.19 in 2022, then increased by 9.68% to 0.2 in 2023, then soared by 73.51% to 0.35 in 2024, then decreased by 27.63% to 0.26 in 2025.
  • Its FCF Payout Ratio stands at 0.26 for Q3 2025, versus 0.35 for Q2 2025 and 0.24 for Q1 2025.